Cite
Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine.
MLA
Winner, Paul K., et al. “Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine.” Headache: The Journal of Head & Face Pain, vol. 59, no. 10, Nov. 2019, pp. 1743–52. EBSCOhost, https://doi.org/10.1111/head.13654.
APA
Winner, P. K., Spierings, E. L. H., Yeung, P. P., Aycardi, E., Blankenbiller, T., Grozinski, W. M., Yang, R., & Ma, Y. (2019). Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine. Headache: The Journal of Head & Face Pain, 59(10), 1743–1752. https://doi.org/10.1111/head.13654
Chicago
Winner, Paul K., Egilius L. H. Spierings, Paul P. Yeung, Ernesto Aycardi, Tricia Blankenbiller, Wolff, Melissa Grozinski, Ronghua Yang, and Yuju Ma. 2019. “Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine.” Headache: The Journal of Head & Face Pain 59 (10): 1743–52. doi:10.1111/head.13654.